Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 764198 in the Blood

Study ID: NCT07308652
Start Date: 2026-02-09
End Date: 2026-03-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

14

Intervention / Treatment

BI 764198

Itraconazole

Sponsor

Boehringer Ingelheim

Source: clinicaltrials.gov

Share:
Add to list

WELL-MPN: A Digital Lifestyle App for Patients With MPNs

Study ID: NCT07349134
Start Date: 2026-06
End Date: 2029-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

75

Intervention / Treatment

WELL-MPN Digital App

Sponsor

Brigham and Women's Hospital

Source: clinicaltrials.gov

Share:
Add to list

NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer

Study ID: NCT07224152
Start Date: 2026-04-30
End Date: 2030-08-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

NBTXR3

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Development Of A Rapid Diagnostic Test To Identify Crimean-Congo Haemorrhagic Fever At The Point-Of-Care

Study ID: NCT06624787
Start Date: 2026-04
End Date: 2027-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

492

Intervention / Treatment

Rapid Diagnostic Test

Sponsor

Liverpool School of Tropical Medicine

Source: clinicaltrials.gov

Share:
Add to list

STRONGER 60+: Assessing the Clinical Effectiveness and Delivery of an Adapted FINGER Model for Brain Health in Primary Care

Study ID: NCT07117916
Start Date: 2026-08-01
End Date: 2028-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

96

Intervention / Treatment

Supervised nutritional guidance, physical exercise, cognitive training, social engagement, and management of vascular and metabolic risk factors.

Sponsor

Karolinska Institutet

Source: clinicaltrials.gov

Share:
Add to list

Developing a Chatbot to Promote HIV Testing

Study ID: NCT04910984
Start Date: 2026-07-20
End Date: 2027-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Chatbot messages

Attention-matched educational materials

Sponsor

Yale University

Source: clinicaltrials.gov

Share:
Add to list

Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell Lymphoma

Study ID: NCT07316010
Start Date: 2026-06-01
End Date: 2031-03-21
Study Type

Interventional

Study Phase

Phase2

No. of Participants

10

Intervention / Treatment

Leukapheresis

Lymphodepleting Chemotherapy

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

Study ID: NCT07318610
Start Date: 2026-03-31
End Date: 2029-08-03
Study Type

Interventional

Study Phase

Phase3

No. of Participants

7050

Intervention / Treatment

REGN7508

Reginasa

Placebo

Rivaroxaban

Sponsor

Regeneron Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Development of a Socially Connected Exercise System for Wheelchair Users

Study ID: NCT07189546
Start Date: 2026-02-16
End Date: 2027-10-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment
Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation

Study ID: NCT06634056
Start Date: 2026-05-30
End Date: 2032-11-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

150

Intervention / Treatment

Pentoxifylline

Placebo

α-Tocopherol

Sponsor

University Health Network, Toronto

Source: clinicaltrials.gov

Share:
Add to list